Ultra-Sensitive Biomarker Detection
Spear Bio develops ultra-sensitive immunoassay kits and services based on its patented SPEAR (Successive Proximity Extension Amplification Reaction) technology. The wash-free, homogeneous platform detects protein biomarkers at attomolar concentrations using 1 µL or less of sample and a standard qPCR workflow, enabling research in neurological diseases including Alzheimer's, TBI, multiple sclerosis, and ALS.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJul 2024
Nov 2023
Oct 2021
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
